Revance Therapeutics, Inc. Business Finance Contracts & Agreements

52 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 1.75% Convertible Senior Notes Due 2027 between Revance Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2025
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Barclays Capital Inc., March 2024
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Description of Revance Therapeutics, Inc. Common and Preferred Stock
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2023
Description of Revance Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Underwriting Agreement between Revance Therapeutics, Inc. and Underwriters (Goldman Sachs, Cowen, Guggenheim) for Common Stock Offering
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Note Purchase Agreement among Revance Therapeutics, Inc., Certain Subsidiaries, Athyrium Buffalo LP, and Purchasers (March 18, 2022)
Note Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2022
Description of Revance Therapeutics, Inc. Common Stock
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Letter Amendment to License Agreement between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Modification Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Grant Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2021
Description of Revance Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
First Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc.
Modification Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Loan Agreement between Revance Therapeutics, Inc. and Hint, Inc. dated May 18, 2020
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Description of Revance Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Indenture for 1.75% Convertible Senior Notes due 2027 between Revance Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Cowen, Piper Jaffray, and Stifel (December 2019)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Underwriting Agreement, dated January 16, 2019, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs & Co. LLC and Cowen and Company, LLC (December 6, 2017)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2017
Common Stock Sales Agreement between Revance Therapeutics, Inc. and Cowen and Company, LLC (March 7, 2016)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2016
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Award Agreement
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
Revance Therapeutics, Inc. Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2016
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Grant Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. 2014 Inducement Plan Stock Option Grant Notice and Option Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. Stock Option Grant Notice and Option Agreement (2014 Equity Incentive Plan)
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2015
Revance Therapeutics, Inc. Underwriting Agreement with Cowen and Company, LLC and Piper Jaffray & Co. (November 3, 2015)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
Common Stock Sales Agreement between Revance Therapeutics, Inc. and Cowen and Company, LLC (March 4, 2015)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
Warrant to Purchase Capital Stock between Revance Therapeutics, Inc. and Essex Capital Corporation (December 20, 2014)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2015
Second Amendment to Loan and Lease Agreement between Essex Capital Corporation and Revance Therapeutics, Inc.
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
First Amendment to Loan and Lease Agreement between Essex Capital Corporation and Revance Therapeutics, Inc.
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Grant Agreement with Participant
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Revance Therapeutics, Inc. 2014 Inducement Plan Stock Option Grant Notice and Option Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Underwriting Agreement between Revance Therapeutics, Inc. and Underwriters (Cowen and Company, LLC, Piper Jaffray & Co.)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
Revance Therapeutics, Inc. 2014 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
Revance Therapeutics, Inc. Common Stock Certificate
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Warrant Agreement to Purchase Preferred Stock between ReVance Therapeutics, Inc. and Hercules Technology Growth Capital, Inc.
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant to Purchase Series Preferred Stock between Revance Therapeutics, Inc. and Holder
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant to Purchase Capital Stock between Revance Therapeutics, Inc. and Essex Capital Corporation
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant Agreement to Purchase Series D Preferred Stock between Revance Therapeutics, Inc. and Essex Capital Corporation (June 2010)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant to Purchase Series Preferred Stock between Revance Therapeutics, Inc. and Holder
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014